OPR - Delayed Quote • USD AUPH Oct 2024 8.000 call (AUPH241018C00008000) Follow 0.3000 +0.0500 (+20.00%) As of April 26 at 2:17 PM EDT. Market Open. Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw Table View List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Date Close Open High Low Volume O H L C Vol AAPL Loading Chart for AUPH241018C00008000 1D 5D 1M 3M 6M YTD 1Y 2Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: AUPH UPDATE: New Aurinia Presentation Details at the 2024 Bloom Burton & Co. Healthcare Investor Conference Aurinia Pharmaceuticals to Release First Quarter Financial and Operational Results on May 2, 2024 Aurinia Will Attend 2024 Bloom Burton & Co. Healthcare Investor Conference When Will Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Breakeven? 11 Oversold Biotech Stocks To Buy Right Now We're Not Worried About Aurinia Pharmaceuticals' (NASDAQ:AUPH) Cash Burn Aurinia Receives Exemptive Relief from Canadian Securities Regulators for Share Repurchase Program Aurinia to Participate in Upcoming Investor Healthcare Conferences Aurinia Pharmaceuticals Full Year 2023 Earnings: EPS Misses Expectations Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q4 2023 Earnings Call Transcript Aurinia Pharmaceuticals (AUPH) Reports Q4 Loss, Tops Revenue Estimates Aurinia Pharmaceuticals Inc (AUPH) Announces Year-End Financial Results and Strategic Initiatives
